High-resolution discrimination of homologous and isomeric proteinogenic amino acids in nanopore sensors with ultrashort single-walled carbon nanotubes.

The hollow and tubular structure of single-walled carbon nanotubes (SWCNTs) makes them ideal candidates for making nanopores. However, the heterogeneity of SWCNTs hinders the fabrication of robust and reproducible carbon-based nanopore sensors. Here we develop a modified density gradient ultracentrifugation approach to separate ultrashort (≈5-10 nm) SWCNTs with a narrow conductance range and construct high-resolution nanopore sensors with those tubes inserted in lipid bilayers. By conducting ionic current recordings and fluorescent imaging of Ca2+ flux through different nanopores, we prove that the ion mobilities in SWCNT nanopores are 3-5 times higher than the bulk mobility. Furthermore, we employ SWCNT nanopores to discriminate homologue or isomeric proteinogenic amino acids, which are challenging tasks for other nanopore sensors. These successes, coupled with the building of SWCNT nanopore arrays, may constitute a crucial part of the recently burgeoning protein sequencing technologies.

Robust α-Fe2O3@TiO2 Core-Shell Structures With Tunable Buffer Chambers for High-Performance Lithium Storage.

α-Fe2O3 has high potential energy storage capacity and can serve as a green and low-cost anode material for lithium-ion batteries. However, α-Fe2O3 suffers large volume expansion and pulverization. Based on DFT calculations, TiO2 can effectively maintain the integrity of the crystal structure during the discharge/charge process. Well-defined cubic α-Fe2O3 is coated with a TiO2 layer using the hydrothermal method with the assistance of oxalic acid surface treatment, and then α-Fe2O3@TiO2 with tunable buffer chambers is obtained by altering the hydrochloric acid etching time. With the joint efforts of the buffer chamber and the robust structure of the TiO2 layer, α-Fe2O3@TiO2 alleviates the expansion of α-Fe2O3 during the discharge/charge process. The optimized sample (FT-1h) achieves good cycling performance. The reversible specific capacity remains at 893.7 mA h g-1, and the Coulombic efficiency still reaches up to 98.47% after 150 cycles at a current density of 100 mA g-1. Furthermore, the reversible specific capacity can return to 555.5 mA h g-1 at 100 mA g-1 after cycling at a high current density. Hence, the buffer chamber and the robust TiO2 layer can effectively improve the cycling stability and rate performance of α-Fe2O3.

Anticancer effect of icaritin inhibits cell growth of colon cancer through reactive oxygen species, Bcl-2 and cyclin D1/E signaling.

Icaritin has an advantage in enhancing immunity. Besides, with its anticancer effect, it may be of great help in cancer treatment and recovery of cancer patients. As a result, icaritin is likely to become a novel anticancer drug. However, the anticancer effect of icaritin against colon cancer has not been elucidated thus far. The present study investigated the latent anticancer effect of icaritin on the inhibition of colon cancer cell growth by regulating reactive oxygen species (ROS), B-cell lymphoma (Bcl)-2 and cyclin D1/E signaling. The COLO-205 colon cancer cell line was used as a colon cancer cell model in the present study. First, cell growth and apoptosis were measured to analyze the anticancer effect of icaritin against colon cancer. Next, the possible mechanism of icaritin against colon cancer, including ROS, Bcl-2, cyclin D1, cyclin E and caspase-3/9, was explored. The results revealed that icaritin could inhibit cell growth and induce the apoptosis of COLO-205 cells. In addition, icaritin significantly induced ROS generation, suppressed Bcl-2, cyclin D1 and cyclin E protein expression, and activated caspase-3/9 activity in COLO-205 cells. The present findings demonstrated that icaritin exerted antiproliferative and anticancer effects against colon cancer through the activation of ROS generation and the suppression of Bcl-2, cyclin D1 and cyclin E signaling.